jueves, 9 de julio de 2020

STAT Plus: A moment of truth arrives for CytoDyn’s Covid-19 drug. Don’t let spin obscure it

By ADAM FEUERSTEIN

When results of the study read out in the next few weeks, the experimental drug leronlimab is unlikely to show meaningful benefit. Here's why.